0.8124
Citius Pharmaceuticals Inc (CTXR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
3.9441
|
- | - | - | - |
| Cost Of Revenue |
0.7892
|
- | - | - | - |
| Gross Profit |
3.1549
|
- | - | - | - |
|
|
44.29%
12.17
|
8.4373 | 8.788 | 11.26 | 10.04 |
| Benefits Costs and Expenses |
13.07
|
- | - | - | - |
| Costs And Expenses |
13.07
|
- | - | - | - |
| Operating Income/Loss |
6.90%
-9.0192
|
-8.4373 | -8.788 | -11.26 | -10.04 |
| Nonoperating Income/Loss |
162.35%
-0.1104
|
-0.0421 | -0.1516 | 0.0134 | 0.0226 |
| Income/Loss From Continuing Operations Before Tax |
7.67%
-9.1296
|
-8.4794 | -8.9396 | -11.25 | -10.28 |
| Income Tax Expense/Benefit, Deferred |
0.00%
0.2642
|
0.2642 | 0.2642 | - | - |
| Income Tax Expense/Benefit |
0.00%
0.2642
|
0.2642 | 0.2642 | 0.2642 | 0.2642 |
| Income/Loss From Continuing Operations After Tax |
7.44%
-9.3939
|
-8.7436 | -9.2039 | -11.51 | -10.28 |
|
|
7.44%
-9.3939
|
-8.7436 | -9.2039 | -11.51 | -10.28 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
49.56%
-1.1731
|
-0.7844 | -0.414 | -0.595 | - |
| Basic Average Shares |
951.18%
21.50
|
2.0449 | 11.01 | 8.5812 | -0.5514 |
| Diluted Average Shares |
951.18%
21.50
|
2.0449 | 11.01 | 8.5812 | -0.5514 |
| Basic Earnings Per Share |
245.45%
-0.38
|
-0.11 | -0.80 | -1.27 | -1.31 |
| Diluted Earnings Per Share |
245.45%
-0.38
|
-0.11 | -0.80 | -1.27 | -1.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):